152 related articles for article (PubMed ID: 22033084)
21. Cell apoptosis and proliferation inhibition of pancreatic cancer induced by sub-threshold focused ultrasound (FUS).
Guo Q; Jiang LX; Hu B
Eur J Radiol; 2012 May; 81(5):e704-7. PubMed ID: 21440395
[TBL] [Abstract][Full Text] [Related]
22. Microbubble-induced sonoporation involved in ultrasound-mediated DNA transfection in vitro at low acoustic pressures.
Qiu Y; Zhang C; Tu J; Zhang D
J Biomech; 2012 May; 45(8):1339-45. PubMed ID: 22498312
[TBL] [Abstract][Full Text] [Related]
23. A novel combination of TRAIL and doxorubicin enhances antitumor effect based on passive tumor-targeting of liposomes.
Guo L; Fan L; Ren J; Pang Z; Ren Y; Li J; Wen Z; Jiang X
Nanotechnology; 2011 Jul; 22(26):265105. PubMed ID: 21586819
[TBL] [Abstract][Full Text] [Related]
24. Short-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer.
Wu SK; Chiang CF; Hsu YH; Lin TH; Liou HC; Fu WM; Lin WL
Int J Nanomedicine; 2014; 9():4485-94. PubMed ID: 25278753
[TBL] [Abstract][Full Text] [Related]
25. Effect of High-Intensity Focused Ultrasound on Drug Release from Doxorubicin-Loaded PEGylated Liposomes and Therapeutic Effect in Colorectal Cancer Murine Models.
Jeong HS; Hwang H; Oh PS; Kim EM; Lee TK; Kim M; Kim HS; Lim ST; Sohn MH; Jeong HJ
Ultrasound Med Biol; 2016 Apr; 42(4):947-55. PubMed ID: 26795498
[TBL] [Abstract][Full Text] [Related]
26. Ultrasound and microbubble-targeted delivery of small interfering RNA into primary endothelial cells is more effective than delivery of plasmid DNA.
Juffermans LJ; Meijering BD; Henning RH; Deelman LE
Ultrasound Med Biol; 2014 Mar; 40(3):532-40. PubMed ID: 24361223
[TBL] [Abstract][Full Text] [Related]
27. Bleomycin delivery into cancer cells in vitro with ultrasound and SonoVue® or BR14® microbubbles.
Lamanauskas N; Novell A; Escoffre JM; Venslauskas M; Satkauskas S; Bouakaz A
J Drug Target; 2013 May; 21(4):407-14. PubMed ID: 23336182
[TBL] [Abstract][Full Text] [Related]
28. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model.
Aryal M; Vykhodtseva N; Zhang YZ; Park J; McDannold N
J Control Release; 2013 Jul; 169(1-2):103-11. PubMed ID: 23603615
[TBL] [Abstract][Full Text] [Related]
29. Lipid/PLGA Hybrid Microbubbles as a Versatile Platform for Noninvasive Image-Guided Targeted Drug Delivery.
Chen Y; Liang Y; Jiang P; Li F; Yu B; Yan F
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41842-41852. PubMed ID: 31633326
[TBL] [Abstract][Full Text] [Related]
30. A Novel Microbubble Capable of Ultrasound-Triggered Release of Drug-Loaded Nanoparticles.
Wang J; Li P; Tian R; Hu W; Zhang Y; Yuan P; Tang Y; Jia Y; Zhang L
J Biomed Nanotechnol; 2016 Mar; 12(3):516-24. PubMed ID: 27280249
[TBL] [Abstract][Full Text] [Related]
31. Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound.
Gao ZG; Fain HD; Rapoport N
J Control Release; 2005 Jan; 102(1):203-22. PubMed ID: 15653146
[TBL] [Abstract][Full Text] [Related]
32. Delivery of systemic chemotherapeutic agent to tumors by using focused ultrasound: study in a murine model.
Yuh EL; Shulman SG; Mehta SA; Xie J; Chen L; Frenkel V; Bednarski MD; Li KC
Radiology; 2005 Feb; 234(2):431-7. PubMed ID: 15671000
[TBL] [Abstract][Full Text] [Related]
33. [Targeting therapy of magnetic doxorubicin liposome in nude mice bearing colon cancer].
Zhou PH; Yao LQ; Qin XY; Shen XZ; Liu YS; Lu WY; Yao M
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2073-6. PubMed ID: 14703420
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of doxorubicin in glioblastoma multiforme following ultrasound-Induced blood-brain barrier disruption as determined by microdialysis.
Lin YL; Wu MT; Yang FY
J Pharm Biomed Anal; 2018 Feb; 149():482-487. PubMed ID: 29175555
[TBL] [Abstract][Full Text] [Related]
35. Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors.
van Lummel M; van Blitterswijk WJ; Vink SR; Veldman RJ; van der Valk MA; Schipper D; Dicheva BM; Eggermont AM; ten Hagen TL; Verheij M; Koning GA
FASEB J; 2011 Jan; 25(1):280-9. PubMed ID: 20876209
[TBL] [Abstract][Full Text] [Related]
36. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
[TBL] [Abstract][Full Text] [Related]
37. Albumin acts like transforming growth factor β1 in microbubble-based drug delivery.
Chuang YH; Wang YH; Chang TK; Lin CJ; Li PC
Ultrasound Med Biol; 2014 Apr; 40(4):765-74. PubMed ID: 24433746
[TBL] [Abstract][Full Text] [Related]
38. Ultrasonically activated chemotherapeutic drug delivery in a rat model.
Nelson JL; Roeder BL; Carmen JC; Roloff F; Pitt WG
Cancer Res; 2002 Dec; 62(24):7280-3. PubMed ID: 12499270
[TBL] [Abstract][Full Text] [Related]
39. Experiment on enhancing antitumor effect of intravenous epirubicin hydrochloride by acoustic cavitation in situ combined with phospholipid-based microbubbles.
Lu CT; Zhao YZ; Wu Y; Tian XQ; Li WF; Huang PT; Li XK; Sun CZ; Zhang L
Cancer Chemother Pharmacol; 2011 Aug; 68(2):343-8. PubMed ID: 20978763
[TBL] [Abstract][Full Text] [Related]
40. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterization.
Tinkov S; Winter G; Coester C; Bekeredjian R
J Control Release; 2010 Apr; 143(1):143-50. PubMed ID: 20060861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
